Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Medicaid Work Requirements
  • ‘Skinny Labeling’
  • Gun Control
  • Suicide Prevention
  • Rural Health Payout

TRENDING TOPICS:

  • Medicaid Work Requirements
  • 'Skinny Labeling'
  • Gun Control
  • Suicide Prevention
  • Rural Health Payout

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Friday, Jul 12 2019

Full Issue

Advocates Worry Trump Will Use Drop In Opioid Deaths As Winning Talking Point When Reality Is More Nuanced

“They’re going to make the political argument that they’re winning,” said Regina LaBelle, the former chief of staff for the Office of National Drug Control Policy during the Obama administration. “Which they can say, since deaths are down. But I get concerned that we’re going to take our eye off the ball on the broader issue of addiction.” Meanwhile, in a battle over Philadelphia's safe injection sites, supporters of the facilities get a boost from other states.

Stat: As Trump Claims Credit For Decline In Opioid Deaths, Others See Signs Of Danger Ahead

Ahead of a 2020 race already focused on health care, President Trump is boasting that his administration played a huge role in achieving the first annual drop in overdose deaths in three decades. The drop, he crowed recently, is “tremendous.” But behind the scenes, his administration’s efforts to address the opioid crisis are increasingly contentious. Two federal agencies are feuding over how to classify certain drugs too dangerous for public consumption. And in the two-plus years since his inauguration, his White House has yet to nominate a leader for the Drug Enforcement Administration. (Facher, 7/12)

The Wall Street Journal: Philadelphia Safe-Injection Site Draws Supporters In Court

Authorities from seven states, the District of Columbia and some major U.S. cities are backing a Philadelphia effort to open a supervised drug-injection site, which the federal government is trying to stop in court. Safehouse, a nonprofit in Philadelphia, seeks to open a site where people can use drugs in a safe and sanitary environment with help to avoid overdose fatalities. Federal prosecutors sued the nonprofit in February, arguing it would violate federal law by creating a place for people to use illegal drugs such as heroin and bootleg fentanyl. (Kamp, 7/11)

NPR: Dozen Local Leaders Ask U.S. Court To OK Injection Site For Opioid Users

Top officials from 13 states are joining Philadelphia in urging a federal court to allow a site to open where people can inject illegal opioids under medical supervision, the latest escalation in a legal battle with the Justice Department that may determine whether such facilities, known as supervised injection sites, can start to operate in America. In Philadelphia, where drug overdoses — most involving opioids — kill three times as many people as homicides, a nonprofit called Safehouse has been working to launch an injection site as a way of combating the city's opioid crisis. (Allyn, 7/11)

And in other news on the epidemic —

Stat: Fewer Opioid Prescriptions Being Written For Medicare Part D

As the U.S. grapples with an ongoing opioid crisis, a new federal government report finds that efforts to rethink physician prescribing practices and provide treatments for people who have abused opioids appear to be working. In 2018, nearly 3 in 10 beneficiaries received at least one prescription opioid through Medicare Part D. Specifically, 29% of beneficiaries, or 13.4 million of the 46.8 million people enrolled in the program, received opioids. (Silverman, 7/11)

Reuters: Lawmakers Seek Scientific Review Of Plan To Tightly Regulate All Fentanyl Copycats

Lawmakers on the U.S. Senate Judiciary Committee have urged the Trump administration to conduct a scientific review of a Justice Department-backed bill to classify all illicit chemical knockoffs of the potent painkiller fentanyl in the same legal category as heroin. The sweeping legislation may "deter valid, critical medical research aimed at responses to the opioid crisis," the senators said in a July 10 letter to Department of Health and Human Services (HHS) Secretary Alex Azar seen by Reuters on Thursday. (Lynch, 7/11)

The Baltimore Sun: Opioid Overdoses, Fatalities For Anne Arundel Continue Decrease Through June

The number of opioid overdoses in the county have continued to decrease with a 25% decline in comparison to 2018. Since the start of 2019 until June 25, 433 overdoses — with 71 fatalities — have occurred with majority of the incidents taking place in the northern part of the county, according to a report by the Anne Arundel Police and the county health department. (Harris, 7/12)

Health News Florida: Drug Deaths In Florida Down In First Half Of 2018

The number of drug-related deaths in Florida, including those caused by opioids, declined in the first six months of 2018, compared to the first half of 2017, according to an interim report released by the state Medical Examiners Commission. There were 107,570 deaths in Florida during the first six months of 2018. Of the cases reviewed by the state’s medical examiners, toxicology results determined that 5,922 cases involved drugs. (Sexton, 7/11)

The Oregonian: Happy Valley Man Who Trafficked In Counterfeit Oxycodone Laced With Fentanyl Sent To Federal Prison

A Happy Valley man who distributed counterfeit oxycodone pills laced with fentanyl was sentenced Thursday to four years and nine months in federal prison. Johnell Lee Cleveland, 37, pleaded guilty to conspiracy to possess with intent to distribute and distribution of controlled substance, possession of an unregistered firearm and two counts of money laundering. (Bernstein, 7/11)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, April 30
  • Wednesday, April 29
  • Tuesday, April 28
  • Monday, April 27
  • Friday, April 24
  • Thursday, April 23
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF